Latest Regulatory Delays News

Page 4 of 15
Orezone Gold Corporation reported a robust 33% increase in revenue for FY2025, underpinned by higher gold prices and the start of hard rock production at Bomboré. The company also announced a strategic acquisition of the Casa Berardi gold mine in Canada.
Maxwell Dee
Maxwell Dee
2 Mar 2026
Platformo Ltd reported a modest 5% revenue increase in 2025 driven by its Malaysian subsidiary Biztrak, but faced a higher net loss due to regulatory delays and increased corporate advisory costs.
Sophie Babbage
Sophie Babbage
27 Feb 2026
Cyclopharm Limited reported a 17% revenue increase to a record $32.3 million in 2025, powered by a 226% surge in US Technegas sales. The company is accelerating its US rollout with plans for up to 300 installations in 2026, while advancing clinical trials beyond pulmonary embolism.
Ada Torres
Ada Torres
25 Feb 2026
Caravel Minerals confirms its Definitive Feasibility Study for the Caravel Copper Project remains on track for mid-2026, while regulatory water investigations push the Final Investment Decision to late 2027. Meanwhile, strategic talks with Adani advance steadily.
Maxwell Dee
Maxwell Dee
25 Feb 2026
Riversgold Limited has resolved all objections to its Mining Lease application for the Northern Zone Gold Project near Kalgoorlie, paving the way for imminent lease approval and advancing its partnership with MEGA Resources.
Maxwell Dee
Maxwell Dee
17 Feb 2026
ADX Energy has restarted flow testing at its Welchau-1 well in Austria after regulatory delays, aiming to confirm the commercial viability of light oil and gas-condensate reservoirs in the Reifling Formation.
Maxwell Dee
Maxwell Dee
12 Feb 2026
Iris Cairns Property Trust has confirmed new funding arrangements and plans to extend its takeover offer period for Reef Casino Trust, navigating regulatory hurdles and reassuring investors of its financial backing.
Victor Sage
Victor Sage
6 Feb 2026
Memphasys has lodged regulatory submissions for its Felix™ System in Australia and India, following CE Mark approval, while progressing UK market entry under the CE Mark transition framework.
Ada Torres
Ada Torres
3 Feb 2026
Cyclopharm has reported a record $32.3 million in operating revenue for FY2025, led by explosive growth in its U.S. Technegas market following FDA approval. The company reaffirms its ambitious target of 250–300 U.S. installations by mid-2026 amid strong clinical momentum.
Ada Torres
Ada Torres
2 Feb 2026
Carbine Resources has secured key access agreements and is progressing regulatory approvals for its silica sand projects, maintaining a strong cash position as field activities prepare to restart in early 2026.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Eastern Resources Limited reports steady progress on its Marengo Gold Project farm-in agreement despite ministerial approval delays, alongside ongoing environmental assessments at Nowa Nowa and a director resignation.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Infinity Metals has completed drilling at its Cobungra Gold-Copper-Silver Project in Victoria, confirming mineralisation over a 2km strike, while awaiting regulatory feedback on its San Jose Lithium Mining Licence Application in Spain.
Maxwell Dee
Maxwell Dee
30 Jan 2026

Browse the archive

Full archive